Intelliheart tests in Amcal pharmacies
Friday, 13 June, 2008
IM Medical (ASX: IMI) has reached an exclusive agreement with Sigma Pharmaceuticals that will see the Intelliheart cardiac risk assessment tests sold through Sigma's Amcal network.
The Amcal network includes over 700 Amcal, Amcal Max and Guardian pharmacies throughout the country.
The product will initially be rolled out to over 200 pharmacies throughout Victoria in July. Stores in other states will begin stocking the product in the next few months.
Under the agreement Sigma has the right to produce and market other products using the Intelliheart brand name.
Intelliheart is the only widely available diagnostic which tests for both heart rate variability and arterial stiffness.
Cannabis use may double risk of cardiovascular disease death
Cannabis users have a 29% higher risk of acute coronary syndrome, a 20% higher risk of stroke,...
Space conditions can lead to periodontitis, scientists say
Living in zero gravity can lead to periodontitis — a serious condition where the gums...
Personalised brain stimulation helps treat those with depression
By tailoring transcranial magnetic stimulation to each person's unique brain structure,...
